Proteintech Announces Completion of Its New GMP Laboratory

June 24, 2019 Off By BusinessWire

ROSEMONT, Ill.–(BUSINESS WIRE)–#GMP–Proteintech, the benchmark in antibodies, announces that construction of its new Good Manufacturing Practice (GMP)-grade laboratory is complete. The facility is located at Proteintech’s headquarters in Rosemont, IL. Proteintech was joined by Mayor Bradley Stephens, Trustee Roger Minale and Trustee Steve Price to commemorate the opening of the new laboratory which will focus on the expansion of Proteintech’s GMP-grade Humankine® line of human cell line-derived growth factors and cytokines for use in the pharmaceutical industry.


“We are living in the golden age of medicine. For the first time in history, mankind has opened the doors to new worlds of cancer immunotherapy with antibodies and T cells, and even tissue regeneration using stem cells,” says Proteintech CEO, Dr. Jason Li, “With the opening of our GMP facility, we at Proteintech are excited to explore these worlds alongside scientists and physicians.”

Humankine® proteins, as authentic human cell-derived proteins, offer a solution to the growing need for effective and safe products for development and scaling of cell therapies. The new state-of-the-art facility has been designed to satisfy federal regulatory requirements to allow protein production to meet the growing need for GMP-grade reagents in the pharmaceutical industry. The future use of the laboratory will also include development of antibodies into diagnostic kits and pharmaceutical drugs.

About Proteintech Group

Proteintech is an antibody and human protein manufacturer selling directly to scientists and only selling its own products to maintain the highest level of quality control leading to superior reproducibility and lot consistency. With over 2/3 of the human genome completed, we have a catalog of over 12,000 antibodies against 12,000 targets covering a wide spectrum of research areas. We have been cited in tens of thousands of publications and provide in-house validation of our antibodies in WB, IHC, IF, FC, IP, and CHIP, in addition to performing knock-down siRNA validation of our antibodies. Additionally, we provide human cell-expressed proteins that have authentic glycosylation and folding, yielding higher activity and stability over proteins from other hosts. To learn more about Proteintech and their mission to deliver products directly from their bench to the researcher’s bench, please visit www.ptglab.com.

 

Contacts

Katie Bellows

[email protected]